APA (7th ed.) Citation

JM, J., TM, R., J, B., S, S., MD, W., H, K., . . . FA, S. (2021). sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection. Frontiers in immunology, 12, 687065. https://doi.org/10.3389/fimmu.2021.687065

Chicago Style (17th ed.) Citation

JM, Jubel, Randau TM, Becker-Gotot J, Scheidt S, Wimmer MD, Kohlhof H, Burger C, Wirtz DC, and Schildberg FA. "SCD28, SCD80, SCTLA-4, and SBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection." Frontiers in Immunology 12 (2021): 687065. https://doi.org/10.3389/fimmu.2021.687065.

MLA (9th ed.) Citation

JM, Jubel, et al. "SCD28, SCD80, SCTLA-4, and SBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection." Frontiers in Immunology, vol. 12, 2021, p. 687065, https://doi.org/10.3389/fimmu.2021.687065.